NCT07437807

Brief Summary

The primary objective of this study is to evaluate the effects of a personalized vision therapy programme tailored to baseline visual-cognitive abilities in treatment-resistant amblyopia. In addition to testing the hypothesis that rehabilitation protocols targeting amblyopia related visual-perceptual and visual-cognitive skills. Spesific aims of this study are:

  1. 1.to identify which visual perceptual skills are most significantly impaired sen patients with amblyopia.
  2. 2.to evaluate whether interventions are targeting fundamental visual perceptual skills are associated with improvements in higher-order visual perceptual skills.
  3. 3.to determine whether vision therapy tailored to individual neuro-visual impairments associated with improvements in binocular function, including streopsis and overall visual perceptual performance.
  4. 4.to ases whether baseline neuro-visual perceptual performance predicts the response to vision therapy in patients with amblyopia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 12, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 12, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 23, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 27, 2026

Completed
Last Updated

March 10, 2026

Status Verified

March 1, 2026

Enrollment Period

1 year

First QC Date

February 23, 2026

Last Update Submit

March 7, 2026

Conditions

Keywords

AmblyopiaVision TherapyVisual Perceptual SkillsVisual-Cognitive SkillsNeuroplasticity

Outcome Measures

Primary Outcomes (1)

  • The Correlation Between Vision Therapy and Visual Cognitive Skills and It's Therapeutic Results in Amblyopia: Associating with Brain Plasticity and Visual Perceptual Skills

    From June 2024 to June 2025

Study Arms (1)

Amblyopia patients enrolled in vision therapy

Amblyopia patients who are unresponsive to treatmens ( occlusion therapy, atropinization, strabismus surgery) and enrolled in vision therapy

Diagnostic Test: Motor Free Perception Vision Test

Interventions

The Motor-Free Visual Perception Test-3 (MVPT-3) represents a significant methodological iteration in the assessment of non-motor visual processing, specifically validated for individuals ranging from 4 to 95 years of age. In pediatric and adolescent contexts (under 18), the MVPT-3 is utilized to isolate cognitive visual-perceptual skills-such as spatial relationships, visual discrimination, figure-ground, and visual closure-from fine motor coordination, which may still be developing or impaired. The test consists of 65 items arranged in a horizontal format to accommodate individuals with hemispatial neglect or limited field of vision. For younger examinees, the assessment is particularly vital for identifying perceptual deficits that may impede academic performance, such as reading fluency or mathematical reasoning, without the results being skewed by the child's handwriting or drawing abilities. By providing age-adjusted normative data, the MVPT-3 allows clinicians to derive standard

Amblyopia patients enrolled in vision therapy

Eligibility Criteria

Age4 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

38 amblyopia patients who are admitted to the Dr.Semrin Timlioğlu İper Clinic and Okan University. During the time period: June 2024-June 2025. Patients are unresponsive to traditional treatments such as: strabismus surgery, occlusion therapy and atropinization. They recieved personalized vision therapy programme based on their visual-cognitive and perceptual skills.

You may qualify if:

  • Ambylopia patient
  • Minimal response to traditional treatments
  • Ages between 4-18
  • Receiving personalized vision therapy
  • Taking the TVPS-3 at least 2 times

You may not qualify if:

  • Responsive to treatment
  • Discontinued vision therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Okan University

Istanbul, Turkey (Türkiye)

Location

Related Links

MeSH Terms

Conditions

Amblyopia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesVision DisordersSensation DisordersNeurologic ManifestationsEye DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor H.Semrin Timlioğlu İper

Study Record Dates

First Submitted

February 23, 2026

First Posted

February 27, 2026

Study Start

June 12, 2024

Primary Completion

June 12, 2025

Study Completion

September 30, 2025

Last Updated

March 10, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in publication

Shared Documents
STUDY PROTOCOL, ICF, CSR, ANALYTIC CODE
Access Criteria
Open access for academics

Locations